Harvard Apparatus Regenerative Technology Inc.
HRGN
$1.87
$0.01991.08%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 337.29% | 5.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 337.29% | 5.36% | |||
| Cost of Revenue | 150.00% | 438.46% | |||
| Gross Profit | 854.55% | -125.58% | |||
| SG&A Expenses | -8.49% | -6.17% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.38% | -5.84% | |||
| Operating Income | 26.57% | 6.16% | |||
| Income Before Tax | 27.74% | 25.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 27.74% | 25.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 27.74% | 25.54% | |||
| EBIT | 26.57% | 6.16% | |||
| EBITDA | 26.64% | 5.97% | |||
| EPS Basic | 31.88% | 29.28% | |||
| Normalized Basic EPS | 31.91% | 11.64% | |||
| EPS Diluted | 31.88% | 29.28% | |||
| Normalized Diluted EPS | 31.91% | 11.64% | |||
| Average Basic Shares Outstanding | 6.06% | 5.32% | |||
| Average Diluted Shares Outstanding | 6.06% | 5.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||